Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CurifyLabs

Explore full profile

Automated compounding systems that help pharmacies make personalized medicines safely and consistently

Helsinki, FinlandFounded 2021Biotech & Life Sciences
Valuation $25–50M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for CurifyLabs and the history behind them.

About CurifyLabs

CurifyLabs is a Helsinki, Finland healthtech company founded in 2021 by Charlotta Topelius and Niklas Sandler Topelius. Its Compounding System Solution combines GMP-manufactured excipient bases, software, integrated quality control and robotics inspired by 3D printing to automate the production of patient-specific medicines in pharmacies and hospital pharmacies. The platform is designed to replace slow, manual workflows with consistent, compliant and more efficient compounding and is already used by customers in Europe and the United States. In July 2026, CurifyLabs raised approximately $14 million (€12 million) in Series A funding co-led by Sandwater and HealthCap, with Tesi and existing investors including Lifeline Ventures participating, to expand in the US, strengthen supply chains and accelerate product development. Charlotta brings commercial leadership as CEO and founder, while Niklas is the pharmacy and technical founder and CTO.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Helsinki, Finland
Sector
Biotech & Life Sciences

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed4 investors entered at this stage

  • Apteekkien Eläkekassa
  • Avohoidon Tutkimussäätiö Sr
  • Lifeline Ventures
  • European Innovation Council

Series A1 investor entered at this stage

  • Springvest

Series B and later4 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇫🇮 Finland74.2%
🇺🇸 United States22.6%
🇩🇪 Germany3.2%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CurifyLabs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CurifyLabs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles